Search Results for 'nci'
nci published presentations and documents on DocSlides.
NCI-Molecular Analysis for Therapy Choice
by conchita-marotz
(NCI-MATCH / EAY131). A phase II precision medic...
NCI Experimental Therapeutics Clinical Trials Network
by tawny-fly
(ETCTN). Central IRB Education Day. 28 April 2015...
NCI in 2017 What’s new in 2017?
by sherrill-nordquist
NCI in 2017 What’s new in 2017? Presented by Th...
Figure S1 . Effect of avutometinib on cell viability of NCI-H358 cells.
by amelia
The NCI-H358 cells were treated with avutometinib ...
hpcdmeweb.nci.nih.gov NCI Data Management
by barbara
Environment. (DME). Downloading a Collection to a...
NCI-Molecular Analysis for Therapy Choice
by phoebe-click
(NCI-MATCH or EAY131). Interim Analysis Results....
NCI ANALYSIS REPORT Larnique Sugick The National
by debby-jeon
NCI ANALYSIS REPORT Larnique Sugick The National C...
NCI Workshop: Issues in Post-Treatment Surveillance
by koa
Lalitha K. Shankar, MD, PhD,. Cancer Imaging Progr...
Individuals With ID/DD Who Communicate Nonverbally
by kamari239
Sarah Taub NCI Webinar Series: . January 28. th. ,...
CRF Harmonization and Standardization
by massimo137
Preparation for a Round 5 . CRF Review . Dianne M...
How Do Services for People with Intellectual and Developmental Disabilities Compare by Race and Eth
by moshe
Sarah Taub NCI Webinar Series. October 29. th. , 2...
Common Terminology Criteria for Adverse Events (CTCAE) v.4:
by ceila
Updating a Cancer Research Standard. . Ann . Sets...
Thank you for joining! Slides and a recording of this webinar will be made available tomorrow
by tracy
: . Presentations | National Core Indicators. and...
NCI Training Funding OpportunitiesThe Government Can HelpSusan Perki
by evans
2
NCI Grant Funding for Trainees
PredoctoralPostdo...
Mapping the NCI Thesaurus and the Collaborative Inter-Lingu
by liane-varnes
Amanda Hicks. University of Florida. aehicks@ufl....
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by mitsue-stanley
S. Percy Ivy, MD. Associate Chief, Senior Investi...
ISAC/ODP Priorities for Improvement
by celsa-spraggs
Where are we now?. 7/18/2016. 1. 2015 IM4Q DATA. ...
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by lois-ondreau
S. Percy Ivy, MD. Associate Chief, Senior Investi...
Using Research to Inform Policy and Practice
by giovanna-bartolotta
Using Research to Inform Policy and Practice Sama...
Center for Biomedical Informatics and Information Technology (CBIIT)
by escapistlego
Presented By: . Anthony Kerlavage and Jose Galvez ...
Role of the Drug Project Team in Formulating the Initial Development Plan of NCI-IND agents
by gelbero
Jeff Moscow, MD. IDB, CTEP. Overall Process of NCI...
Collaboration Opportunities to Further Advance ITCR Platforms
by keywordsgucci
Tony Dickherber. NCI, Center for Strategic Scienti...
Basic Group Accounts – F1 Syllabus – Part 3
by dayspiracy
. Management Level – Paper . F2. Advanced Financ...
NCI Division of Cancer Prevention
by celsa-spraggs
NCI Division of Cancer Prevention Ongoing Activi...
Center for Strategic Scientific Initiatives (CSSI)
by liane-varnes
Presented By: . Michelle Berny-Lang. October 1, 2...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
Precision Medicine Clinical Trial Designs
by luanne-stotts
2018 . AACR Annual Meeting. April 15, 2018 . Edwa...
Immuno-Oncology Translational Network (IOTN)
by luanne-stotts
Pre-Application Webinar. RFA-CA-19-015: Cancer Im...
HHS SBIR Contract RFP Informational
by alexa-scheidler
Webinar PHS 2019-1. August 16, 2018. NIH and CDC ...